5F-CUMYL-P7AICA

5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug.^{[1][2][3][4][5][6]} It was first identified by the EMCDDA in February 2015.^[7]

5F-CUMYL-P7AICA

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act US: Schedule I
Identifiers
IUPAC name 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)pyrrolo[2,3-b]pyridine-3-carboxamide
CAS Number	2171492-36-5
PubChem CID	129532613
ChemSpider	68028038
UNII	V3J3TQ3UPP
Chemical and physical data
Formula	C22H26FN3O
Molar mass	367.468 g·mol−1
3D model (JSmol)	Interactive image
SMILES FCCCCCn1cc(c3cccnc13)C(=O)NC(C)(C)c2ccccc2
InChI InChI=1S/C22H26FN3O/c1-22(2,17-10-5-3-6-11-17)25-21(27)19-16-26(15-8-4-7-13-23)20-18(19)12-9-14-24-20/h3,5-6,9-12,14,16H,4,7-8,13,15H2,1-2H3,(H,25,27) Key:MXJYOUMYJGNQEY-UHFFFAOYSA-N

See also

• 5F-A-P7AICA^[8]
• 5F-AB-P7AICA^[8]
• 5F-CUMYL-PINACA
• 5F-MDMB-P7AICA^[8]
• 5F-PCN
• 5F-SDB-006
• ADB-P7AICA